Has Helen Tran, MD received payments from drug or device companies?

Yes. Drug and device makers reported $743 in general payments to Helen Tran, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Helen Tran, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Helen Tran, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Helen Tran, MD

Family Medicine · Long Beach, CANPI 1811925233

Payments from drug & device makers

$743in general payments, 2019–2025

Across 24 payments — averaging $30.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$289
Melinta Therapeutics, LLC$125
UCB, Inc.$85
AstraZeneca$75
Merck$43
Novo Nordisk$38
plus $90 from 3 others

What the payments were for

Food & beverage$743100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	10	$289
Melinta Therapeutics, LLC	1	$125
UCB, Inc.	2	$85
AstraZeneca(2 entities)	3	$75
Merck	2	$43
Novo Nordisk	2	$38
Johnson & Johnson	2	$33
GSK	1	$31
Nevro Corp.	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Vabomere$125

How this compares

$743 in reported general payments places this provider in the 70th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California →

Medicare billing

Part B allowed, 2024

$2,806

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Monohydrate	16	$1,298
Carbamazepine	13	$1,246
Levetiracetam	12	$1,056
Phenobarbital	28	$952
Baclofen	37	$852
Risperidone	38	$798
Quetiapine Fumarate	14	$549
Albuterol Sulfate HfaAlbuterol Sulfate	15	$474
Montelukast Sodium	27	$458
Tamsulosin Hcl	13	$277
Diazepam	25	$271
Finasteride	17	$234
Omeprazole	16	$228
Clotrimazole	11	$207
Clonazepam	11	$195

Paid to pharmacies, not to this prescriber.

Other family medicine in Long Beach

Steven ReynoldsLong Beach$53M
Jack VuLong Beach$10.1M
Amina HaggagNorthridge$112.8M
Rizwana MohseniLake Forest$26.7M
Daniel JohnsonSan Diego$15.7M
Stacey LayleSan Diego$14.8M
Apinya VutikullirdCypress$14.3M
Hanid AudishSpring Valley$13.6M
Augusto FocilOxnard$12.6M
Suzanne FussellOxnard$8.9M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →